Like a partial agonist, YK11 only partially activates androgen receptors and can contend specifically with endogenous Testosterone and DHT for receptor activation.Along with its capacity to induce advancement in muscle mass and bone tissue, investigate is presently getting carried out to look at the anti-cancer outcomes most likely elicited by Anda